Linezolid Dosing Strategies in Drug-Resistant TB

Conditions:   Tuberculosis, Multidrug-Resistant;   Tuberculosis;   Tuberculosis, Pulmonary Interventions:   Drug: Linezolid 600 mg;   Drug: Linezolid 1200 mg (QD);   Drug: Linezolid 1200 mg (TIW);   Drug: Bedaquiline 200 mg;   Drug: Bedaquiline 100 mg;   Drug: Delamanid 300 mg;   Drug: Clofazimine 300 mg;   Drug: Clofazimine 100 mg Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials